Substrate signaling by insulin: A ketone bodies ratio mimics insulin action in heart

American Journal of Cardiology

Volumn 80, Issue 3 A, 1997, Pages 50A-64A

  Kashiwaya, Yoshihiro ^a   King, M Todd ^a   Veech, Richard L ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; ACETYL COENZYME A; GLUCOSE TRANSPORTER; GLYCOGEN SYNTHASE; PYRUVATE DEHYDROGENASE;

CONFERENCE PAPER; ENZYME MECHANISM; GLUCOSE TRANSPORT SYSTEM; GLUCOSE UTILIZATION; GLYCOGEN SYNTHESIS; HEART FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

EID: 0030862656     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00458-X     Document Type: Conference Paper

References (55)

1. Cheung JY, Conover C, Regen DM, Whitfield CF, Morgan HE. Effect of insulin on kinetics of sugar transport in heart muscle. Am J Physiol. 234:1978;E70-E78.
2. Simpson IA, Cushman SW. Hormonal regulation of mammalian glucose transport. Annu Rev Biochem. 55:1986;1059-1089.
3. Larner J, Lawrence JC, Walkenbach RJ, Roach PJ, Hazen RJ, Huang LC. Insulin control of glycogen synthesis. Adv Cyclic Nucleotide Res. 9:1978;425-439.
4. Denton RM, Randle PJ, Bridges BJ, Cooper RH, Kerbey AL, Pask HT, Severson DL, Stansbie D, Whitehouse S. Regulation of mammalian pyruvate dehydrogenase. Mol Cell Biochem. 9:1975;27-53.
5. Mukherjee C, Jungas RL. Activation of pyruvate dehydrogenase in adipose tissue by insulin. Evidence for an effect of insulin on pyruvate dehydrogenase phosphate phosphatase. Biochem J. 148:1975;229-235.
6. Randle PJ, Denton RM, Pask HT, Severson DL. Calcium ions and the regulation of pyruvate dehydrogenase. Biochem Soc Symp. 39:1974;75-88.
7. Sodi-Pallares D, Testelli MR, Fishleder BL, Bisteni A, Medrano GA, Friedland C, Micheli AD. Effects of an intravenous infusion of potassium-glucose-insulin solution on the electrographic signs of myocardial infaraction. Am J Cardiol. 9:1962;166-181.
8. Rackley CE, Russell RO Jr, Rogers WJ, Mantle JA, McDaniel HG, Papapietro SE. Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction. Am Heart J. 102:1981;1038-1049.
9. Muller JE, Mochizuki S, Koster JK Jr, Collins JJ Jr, Cohn LH, Neely JR. Insulin therapy for depressed myocardial contractility after prolonged ischemia. Am J Cardiol. 41:1978;1215-1221.
10. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 343:1994;155-158.
11. Taegtmeyer H. The use of hypertonic glucose, insulin, and potassium (GIK) in myocardial preservation. J Appl Cardiol. 6:1991;255-259.
12. McDaniel HG, Papapietro SE, Rogers WJ, Mantle JA, Smith LR, Russell RO Jr, Rackley CE. Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with acute myocardial infarction. Am Heart J. 102:1981;10-15.
13. Cross HR, Clarke K, Opie LH, Radda GK. Is lactate-induced myocardial ischaemic injury mediated by decreased pH or increased intracellular lactate? J Mol Cell Cardiol. 27:1995;1369-1381.
14. Cahill GF Jr. Starvation in man. N Engl J Med. 282:1970;668-675.
15. Sato K, Kashiwaya Y, Keon CA, Tsuchiya N, King MT, Radda GK, Chance B, Clarke K, Veech RL. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J. 9:1995;651-658.
16. Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fell DA, Veech RL, Passonneau JV. Control of glucose utilization in working perfused rat heart. J Biol Chem. 269:1994;25502-25514.
17. 31P NMR. J Biol Chem. 271:1996;21142-21150.
18. 2+ concentrations. J Biol Chem. 248:1973;4811-4819.
19. Chance B, Leigh JSJ, Kent J, McCully K, Nioka S, Clark BJ, Maris JM, Graham T. Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance. Proc Natl Acad Sci USA. 83:1986;9458-9462.
20. Veech RL, Lawson JWR, Cornell NW, Krebs HA. Cytosolic phosphorylation potential. J Biol Chem. 254:1979;6538-6547.
21. Passonneau JV, Schwartz JP, Rottenberg DA. The partial purification and properties of pig brain glycogen synthase. J Biol Chem. 250:1975;2287-2292.
22. Michaelis L, Menten ML. Die Kinetik der Invertinwirkung. Biochem Z. 49:1913;333-369.
23. Haldane JBS. Enzymes. 1930;74-92 Longmans, Green, London.
24. Kacser H, Burns JA. The control of flux. Symp Soc Exp Biol. 27:1973;65-104.
25. Purich DL, Fromm HJ, Rudolph FB. The hexokinases: kinetic, physical, and regulatory properties. Adv Enzymol Relat Areas Mol Biol. 39:1973;249-326.
26. Casazza JP, Veech RL. The interdependence of glycolytic and pentose cycle intermediates in ad libitum fed rats. J Biol Chem. 261:1986;690-698.
27. Randle PJ. Metabolic fuel selection: general integration at the whole-body level. Proc Nutr Soc. 54:1995;317-327.
28. Williamson JR, Krebs HA. Acetoacetate as fuel of respiration in the perfused rat heart. Biochem J. 80:1961;540-547.
29. Taegtmeyer H, Hems R, Krebs HA. Utilization of energy-providing substrates in the isolated working rat heart. Biochem J. 186:1980;701-711.
30. Halestrap AP, Denton RM. The specificity and metabolic implications of the inhibition of pyruvate transport in isolated mitochondria and intact tissue preparations by α -cyano-4-hydroxycinnamate and related compounds. Biochem J. 148:1975;97-106.
31. Williamson DH, Lund P, Krebs HA. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J. 103:1967;514-527.
32. Krebs HA, Veech RL. The energy and metabolic control in mitochondria. 1969;329-382 Adriatica Editrice, Bari.
33. Ozawa K, Aoyama H, Yasuda K, Shimahara Y, Nakatani T, Tanaka J, Yamamoto M, Kamiyama Y, Tobe T. Metabolic abnormalities associated with postoperative organ failure. A redox theory. Arch Surg. 118:1983;1245-1251.
34. Tanaka A, Kitai T, Tokuka A, Inomoto T, Kim HJ, Tanaka K, Yamaoka Y, Ozawa K. Increased span of oxido-reduction states between pyridine nucleotide and cytochrome c oxidase in the regenerating rabbit liver as measured by arterial ketone body ratio and near-infrared spectroscopy. Res Exp Med (Berlin). 193:1993;353-359.
35. + in determining impermeant intracellular anionic charge and energy of metabolic reactions. Alcohol Clin Exp Res. 18:1994;1040-1056.
36. 2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions. J Biol Chem. 254:1979;6528-6537.
37. 31P magnetic resonance spectroscopy of the Sherpa heart: a phosphocreatine/adenosine triphosphate signature of metabolic defense against hypobaric hypoxia. Proc Natl Acad Sci USA. 93:1996;1215-1220.
38. Klingenberg M. Metabolite transport in mitochondria: an example for intracellular membrane function. Essays Biochem. 6:1970;119-159.
39. Coty WA, Pedersen PL. Phosphate transport in rat liver mitochondria. Kinetics and energy requirements. J Biol Chem. 249:1974;2593-2598.
40. Masuda T, Dobson GP, Veech RL. The Gibbs-Donnan near-equilibrium system of heart. J Biol Chem. 265:1990;20321-20334.
41. 2+ homeostasis in heart and liver cells. Magnes Res. 5:1992;131-137.
42. Veech RL, Kashiwaya Y, King MT. The resting potential of cells are measures of electrical work not of ionic currents. Int Physiol Behav Sci. 30:1995;283-306.
43. Denton RM, McCormack JG, Midgley PJ, Rutter GA. Hormonal regulation of fluxes through pyruvate dehydrogenase and the citric acid cycle in mammalian tissues. Biochem Soc Symp. 54:1987;127-143.
44. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J. Transient increase in obese gene expression after food intake or insulin administration. Nature. 377:1995;527-529.
45. Apstein CS, Gravino FN, Haudenschild CC. Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion. Circ Res. 52:1983;515-526.
46. Mantle JA, Rogers WJ, Smith LR, McDaniel HG, Papapietro SE, Russell RO Jr, Rackley CE. Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction: results from a randomized clinical trial. Am Heart J. 102:1981;313-324.
47. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. Brain metabolism during fasting. J Clin Invest. 46:1967;1589-1595.
48. Veech RL. The toxic impact of parenteral solutions on the metabolism of cells: a hypothesis for physiological parenteral therapy. Am J Clin Nutr. 44:1986;519-551.
49. Chan L, Slater J, Hasbargen J, Herndon DN, Veech RL, Wolf S. Neurocardiac toxicity of racemic D,L-lactate fluids. Integr Physiol Behav Sci. 29:1994;383-394.
50. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 345:1995;669-685.
51. Seelig MS, Elin RJ. Is there a place for magnesium in the treatment of acute myocardial infarction? Am Heart J. 132:1996;471-477.
52. McLean RM. Magnesium and its therapeutic uses: a review. Am J Med. 96:1994;63-76.
53. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC (Atherosclerosis Risk in Communities) study. J Clin Epidemiol. 48:1995;927-940.
54. Ozono R, Oshima T, Matsuura H, Higashi Y, Ishida T, Watanabe M, Yoshimura M, Hiraga H, Ono N, Kajiyama G. Systemic magnesium deficiency disclosed by magnesium loading test in patients with essential hypertension. Hypertens Res. 18:1995;39-42.
55. Rasmussen HS, McNair P, Goransson L, Balslov S, Larsen OG, Aurup P. Magnesium deficiency in patients with ischemic heart disease with and without acute myocardial infarction uncovered by an intravenous loading test. Arch Intern Med. 148:1988;329-332.